OTCMKTS:TGAN Transphorm (TGAN) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free TGAN Stock Alerts $4.79 -0.01 (-0.21%) (As of 04/19/2024 ET) Add Compare Share Share Today's Range$4.60▼$4.8250-Day Range$4.79▼$4.9352-Week Range$1.94▼$4.96Volume382,906 shsAverage Volume405,691 shsMarket Capitalization$303.09 millionP/E RatioN/ADividend YieldN/APrice Target$5.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesOwnershipSEC FilingsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesOwnershipSEC Filings Get Transphorm alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Transphorm Stock (OTCMKTS:TGAN)Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications. The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.Read More TGAN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TGAN Stock News HeadlinesFebruary 7, 2024 | seekingalpha.comTransphorm: Deal Likely Done Even If Not Everyone Is HappyFebruary 6, 2024 | stockhouse.comTransphorm at APEC 2024: SuperGaN Innovation for Low to High Power ApplicationsApril 20, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.January 16, 2024 | finance.yahoo.comTransphorm to Present at the 26th Annual Needham Growth ConferenceDecember 30, 2023 | markets.businessinsider.comTransphorm Buy Rating: Strategic Financial Moves and Acquisition Potential Fuel Growth ProspectsNovember 11, 2023 | finance.yahoo.comTransphorm, Inc. (NASDAQ:TGAN) Q2 2024 Earnings Call TranscriptNovember 9, 2023 | finance.yahoo.comTransphorm Announces Fiscal 2024 Second Quarter Results and Provides Business UpdateNovember 8, 2023 | finance.yahoo.comTransphorm, Inc.'s (NASDAQ:TGAN) largest shareholders are private equity firms with 48% ownership, institutions own 16%April 20, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.October 26, 2023 | tmcnet.comTransphorm to Announce Fiscal 2024 Second Quarter Results and Business Update Call on November 9th at 5:00pmOctober 26, 2023 | businesswire.comTransphorm’s Top-Side Cooled TOLT FET Delivers Superior Thermal and Electrical Performance for Computing, AI, Energy, and Automotive Power SystemsOctober 26, 2023 | finance.yahoo.comTransphorm to Announce Fiscal 2024 Second Quarter Results and Business Update Call on November 9th at 5:00pm ETOctober 14, 2023 | msn.comBenchmark Maintains Transphorm (TGAN) Buy RecommendationSeptember 28, 2023 | finanznachrichten.deTransphorm, Inc.: Transphorm at electronica India 2023: High Voltage SuperGaN Solutions Boosting Electric Vehicle PerformanceSeptember 28, 2023 | finance.yahoo.comInvestors Still Waiting For A Pull Back In Transphorm, Inc. (NASDAQ:TGAN)September 6, 2023 | finance.yahoo.comNew Transphorm White Paper: Normally-Off D-Mode GaN Advantages Vs. Normally-Off E-Mode GaNAugust 22, 2023 | finance.yahoo.comTransphorm to Participate in Upcoming Semiconductor ConferencesAugust 21, 2023 | msn.comTransphorm Stock: Maybe Not Fast EnoughAugust 15, 2023 | markets.businessinsider.comTransphorm (TGAN) Receives a Buy from Benchmark Co.August 14, 2023 | finance.yahoo.comTransphorm Announces Fiscal 2024 First Quarter Results and Provides Business UpdateAugust 9, 2023 | tmcnet.comTransphorm's GaN First to Hit Short Circuit Robustness Milestone Key to Motor Drive ApplicationsAugust 8, 2023 | tmcnet.comTransphorm to Announce Fiscal 2024 First Quarter Results and Business Update Call on August 14th at 5:00August 8, 2023 | finance.yahoo.comTransphorm to Announce Fiscal 2024 First Quarter Results and Business Update Call on August 14th at 5:00 p.m. ETJuly 25, 2023 | finance.yahoo.comTransphorm Announces Results of Rights OfferingJuly 6, 2023 | finance.yahoo.comTransphorm Confirms Gallium Nitride Materials Sources Are SecureJuly 5, 2023 | finance.yahoo.comTransphorm Announces Commencement of Rights OfferingJuly 2, 2023 | finance.yahoo.comTransphorm, Inc. (NASDAQ:TGAN) Q4 2023 Earnings Call TranscriptSee More Headlines Receive TGAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Transphorm and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/20/2024Today4/20/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorComputer and Technology Industry Semiconductor Equipment & Materials Sub-IndustryN/A Current SymbolOTCMKTS:TGAN CUSIPN/A CIK1715768 Webwww.transphormusa.com Phone805-456-1300FaxN/AEmployees128Year FoundedN/APrice Target and Rating Average Stock Price Target$5.75 High Stock Price Target$8.00 Low Stock Price Target$3.50 Potential Upside/Downside+20.0%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-30,600,000.00 Net Margins-189.65% Pretax Margin-189.65% Return on Equity-114.30% Return on Assets-65.96% Debt Debt-to-Equity RatioN/A Current Ratio2.45 Quick Ratio1.38 Sales & Book Value Annual Sales$18.76 million Price / Sales16.16 Cash FlowN/A Price / Cash FlowN/A Book Value$0.33 per share Price / Book14.52Miscellaneous Outstanding Shares63,275,000Free Float60,188,000Market Cap$303.09 million OptionableNot Optionable Beta0.58 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Primit A. Parikh Ph.D. (Age 52)Co-Founder, President, CEO & Director Comp: $390.66kMr. Cameron McAulay (Age 48)Chief Financial Officer Comp: $350.66kDr. Umesh K. Mishra Ph.D. (Age 66)Chairman & CTO Comp: $180kMr. Philip ZukSenior Vice President of Business Development & MarketingMr. Tushar DhayagudeVice President of Worldwide Sales & FAEMr. Randy BergHuman Resources LeaderMr. Sal BarlettSenior Vice President of OperationsMore ExecutivesKey CompetitorsClimb Global SolutionsNASDAQ:CLMBDomoNASDAQ:DOMOOusterNYSE:OUSTSpokNASDAQ:SPOKGilat Satellite NetworksNASDAQ:GILTView All CompetitorsInsidersPhorm Investors L.P. KkrBought 1,735,988 shares on 7/21/2023Total: $5.73 M ($3.30/share) TGAN Stock Analysis - Frequently Asked Questions Should I buy or sell Transphorm stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Transphorm in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TGAN shares. View TGAN analyst ratings or view top-rated stocks. What is Transphorm's stock price target for 2024? 2 Wall Street analysts have issued 1-year target prices for Transphorm's stock. Their TGAN share price targets range from $3.50 to $8.00. On average, they anticipate the company's stock price to reach $5.75 in the next twelve months. This suggests a possible upside of 20.0% from the stock's current price. View analysts price targets for TGAN or view top-rated stocks among Wall Street analysts. How have TGAN shares performed in 2024? Transphorm's stock was trading at $3.65 at the start of the year. Since then, TGAN stock has increased by 31.2% and is now trading at $4.79. View the best growth stocks for 2024 here. How were Transphorm's earnings last quarter? Transphorm, Inc. (OTCMKTS:TGAN) announced its earnings results on Tuesday, February, 20th. The company reported ($0.20) EPS for the quarter. The business had revenue of $4.67 million for the quarter. Transphorm had a negative trailing twelve-month return on equity of 114.30% and a negative net margin of 189.65%. How do I buy shares of Transphorm? Shares of TGAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TGAN) was last updated on 4/20/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Transphorm, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.